Dec 10, 2012
By:
Stephanie Sutton
The Court of Justice of the European Union has dismissed an appeal by AstraZeneca concerning a 2005 decision that found the company guilty of abusing its dominant position in the marketplace.
|
Dec 3, 2012
By:
Stephanie Sutton
The European Medicines Agency has published a plan to help Europe?s regulatory network prevent, mitigate and manage shortages of important medicines following manufacturing problems.
|
Nov 26, 2012
By:
Stephanie Sutton
The European Commission (EC) is seeking to introduce a black symbol to identify medicines that are subject to additional monitoring.
|
Nov 21, 2012
By:
Stephanie Sutton
More favourable conditions for the pharmaceutical industry, including a "golden era of renewed productivity and prosperity" have been forecast in a new report from analyst firm PricewaterhouseCoopers (PwC).
|
Nov 14, 2012
By:
Stephanie Sutton
The European Fine Chemicals Group has proposed that mandatory inspections be introduced for all global API manufacturers wishing to supply the European Union market.
|
Nov 6, 2012
By:
Stephanie Sutton
The European Commission (EC) has issued final approval for Europe’s first gene therapy; a treatment for a rare genetic disorder that currently has no other treatment options.
|
Oct 22, 2012
By:
Stephanie Sutton
Dr Reddy's is planning to acquire the specialty injectable company OctoPlus for approximately EUR27.4 million ($35.7 million) in cash to strengthen its technological capabilities in drug delivery.
|
Oct 15, 2012
By:
Stephanie Sutton
GlaxoSmithKline (GSK) has outlined the measures it is taking as part of a new open innovation approach to R&D, including opening up its tuberculosis compound library, investing in its open laboratory in Spain, and sharing detailed clinical trial data with researchers.
|
Oct 8, 2012
By:
Stephanie Sutton
Takeda's US subsidiary, Takeda America Holdings, is to acquire the vaccine specialist company LigoCyte Pharmaceuticals for an upfront payment of $60 million in a move intended to bolster and expand the company’s vaccine business.
|
|
